These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 756722

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W.
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [Abstract] [Full Text] [Related]

  • 5. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M, Beck P.
    Acta Med Hung; 1986 Nov; 43(3):301-10. PubMed ID: 2438639
    [Abstract] [Full Text] [Related]

  • 6. [Oral contraceptive agents and antithrombin III].
    Kamenov V, Nalbanski B.
    Akush Ginekol (Sofiia); 1990 Nov; 29(1):60-3. PubMed ID: 1695492
    [Abstract] [Full Text] [Related]

  • 7. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC, Montes MB, Franceschini SA, Toloi MR.
    Int J Fertil Womens Med; 2001 Nov; 46(5):265-70. PubMed ID: 11720199
    [Abstract] [Full Text] [Related]

  • 8. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J, Daly L, Carroll E.
    Int J Fertil; 1987 Nov; 32 Suppl():21-8. PubMed ID: 2906344
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A, Bonnar J.
    J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
    [Abstract] [Full Text] [Related]

  • 12. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR.
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [Abstract] [Full Text] [Related]

  • 13. A multicentre study of coagulation and haemostatic variables during oral contraception: variations with four formulations. Task Force on Oral Contraceptives--WHO Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland.
    Br J Obstet Gynaecol; 1991 Nov; 98(11):1117-28. PubMed ID: 1760424
    [Abstract] [Full Text] [Related]

  • 14. Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems.
    Gevers Leuven JA, Kluft C, Bertina RM, Hessel LW.
    J Lab Clin Med; 1987 Jun; 109(6):631-6. PubMed ID: 3108429
    [Abstract] [Full Text] [Related]

  • 15. The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis.
    Hedlin AM.
    Thromb Diath Haemorrh; 1975 Apr 30; 33(2):370-8. PubMed ID: 1138426
    [Abstract] [Full Text] [Related]

  • 16. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul 30; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 17. Long-term profile of a new progestin.
    Lippman J.
    Int J Fertil; 1992 Jul 30; 37 Suppl 4():218-22. PubMed ID: 1362189
    [Abstract] [Full Text] [Related]

  • 18. Effect of four oral contraceptives on hemostatic parameters.
    Wiegratz I, Lee JH, Kutschera E, Winkler UH, Kuhl H.
    Contraception; 2004 Aug 30; 70(2):97-106. PubMed ID: 15288212
    [Abstract] [Full Text] [Related]

  • 19. Serial changes in plasma fibrinogen concentration and fibrinolytic activity in African women on oral contraceptive pills.
    Famodu AA.
    Afr J Reprod Health; 1997 Sep 30; 1(2):90-5. PubMed ID: 10214418
    [Abstract] [Full Text] [Related]

  • 20. Progestational agents and blood coagulation. VI. Relationship of ABO blood types to changes induced by oral contraceptives.
    Lillie MA, Mink IB.
    Am J Obstet Gynecol; 1974 Jun 01; 119(3):406-10. PubMed ID: 4827381
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.